Dr. Shravani Durbhakula 与 Jeremy Kourvelas 撰文呼吁 FDA 为应对新兴药物威胁的临床检测建立快速通道
The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas. htt...
AI 导读
Dr. Shravani Durbhakula 与 Jeremy Kourvelas 撰文提出，FDA 应针对新兴药物威胁建立临床检测的加速审批通道。文章指出，快速通道可让临床检测更快应对新出现的药物威胁。